Form D · Biotechnology
Torus Biosystems, Inc.
Cambridge, MA · CIK 0001802637
Offering snapshot reported May 5, 2021 · SEC filing
- Reported sold
- $25.2M Offering amount: $25.2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 23, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2021 | Initial | $25,214,240 | No comparison | 6 | SEC filing |
| Mar 18, 2021 | Amendment | $2,175,000 | $175,000vs Dec 29, 2020 | 4 | SEC filing |
| Dec 29, 2020 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Feb 7, 2020 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398274
Source: Form D, filed May 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Philip Gardella | Executive |
| Ben Linden | Executive |
| Shawn Marcell | Director, Executive |
| Chenyang Victor Shi | Director |
| Adam Wiechhaus | Director |
| Peng Yin | Director |
| David Yu Zhang | Director |
| David Yu Zhang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
125 Cambridge Park Drive Fifth Floor
Cambridge, MA, 02140
Cambridge, MA, 02140